The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
Open accessAbstract
BACKGROUND: In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the United States for use in young children. METHODS: We examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease, defined by isolation of Streptococcus pneumoniae from a normally sterile site. Serotyping and susceptibility testing of isolates were performed. We assessed trends using data from seven geographic areas with continuous participation from 1998 through 2001 (population, 16 million). RESULTS: The rate of invasive disease dropped from an average of 24.3 cases per 100,000 persons in 1998 and 1999 to 17.3 per 100,000 in 2001. The largest decline was in children under two years of age. In this group, the rate of disease was 69 percent lower in 2001 than the base-line rate (59.0 cases per 100,000 vs. 188.0 per 100,000, P<0.001); the rate of disease caused by vaccine and vaccine-related serotypes declined by 78 percent (P<0.001) and 50 percent (P<0.001), respectively. Disease rates also fell for adults; as compared with base line, the rate of disease in 2001 was 32 percent lower for adults 20 to 39 years of age (7.6 cases per 100,000 vs. 11.2 per 100,000, P<0.001), 8 percent lower for those 40 to 64 years of age (19.7 per 100,000 vs. 21.5 per 100,000, P=0.03), and 18 percent lower for those 65 years of age or more (49.5 per 100,000 vs. 60.1 per 100,000, P<0.001). The rate of disease caused by strains that were not susceptible to penicillin was 35 percent lower in 2001 than in 1999 (4.1 cases per 100,000 vs. 6.3 per 100,000, P<0.001). CONCLUSIONS: The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. The vaccine provides an effective new tool for reducing disease caused by drug-resistant strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surveillance for Foodborne Disease Outbreaks—United States, 2006
(2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.11.004 · Cited by 2,361
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Healthy People 2010: Understanding and Improving Health: (319432004-001)
US Department of Health & Human Services Office of Disease Prevention and Health Promotion (2000) · PsycEXTRA Dataset · doi:10.1037/e319432004-001 · Cited by 2,178
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A., Käyhty, H., Karma, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,455
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Self-citationCigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Self-citationBLACK, S. B., SHINEFIELD, H. R., LING, S., HANSEN, J., FIREMAN, B., SPRING, D., NOYES, J., LEWIS, E., RAY, P., LEE, J., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200209000-00005 · Cited by 616
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315009 · Cited by 515
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citationBradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationStreptococcus pneumoniae: transmission, colonization and invasion
Weiser, J. N., Ferreira, D. M., & Paton, J. C. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0001-8 · Cited by 1,098
Clinical and economic burden of community-acquired pneumonia among adults in Europe
Welte, T., Torres, A., & Nathwani, D. (2012) · Thorax · doi:10.1136/thx.2009.129502 · Cited by 1,033
Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035060 · Cited by 1,009
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Self-citationVaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Self-citationGuidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
Diagnosis and Management of Acute Otitis Media
Media, S. O. M. O. A. O. (2004) · Pediatrics · doi:10.1542/peds.113.5.1451 · Cited by 902
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., Thomas, A. R., Harrison, L. H., Bennett, N. M., Farley, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051642 · Cited by 881
Self-citationCommunity-Acquired Bacterial Meningitis in Adults
van de Beek, D., de Gans, J., Tunkel, A. R., & Wijdicks, E. F. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052116 · Cited by 880
Bacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70189-4 · Cited by 851
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Hicks, L. A., Harrison, L. H., Flannery, B., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D., Thomas, A., Beall, B., Lynfield, R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521626 · Cited by 737
Self-citationImpact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671
Grijalva, C. G., Nuorti, J. P., Arbogast, P. G., Martin, S. W., Edwards, K. M., & Griffin, M. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60564-9 · Cited by 667
Miller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
Singleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K., & Parkinson, A. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615
Epidemiological differences among pneumococcal serotypes
Hausdorff, W. P., Feikin, D. R., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01280-6 · Cited by 606
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children
Bogaert, D., van Belkum, A., Sluijter, M., Luijendijk, A., de Groot, R., Rümke, H., Verbrugh, H., & Hermans, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16357-5 · Cited by 592
A role for Streptococcus pneumoniae in virus-associated pneumonia
Madhi, S. A., Klugman, K. P., & The Vaccine Trialist Group (2004) · Nature Medicine · doi:10.1038/nm1077 · Cited by 565
Johnson, H. L., Deloria-Knoll, M., Levine, O. S., Stoszek, S. K., Freimanis Hance, L., Reithinger, R., Muenz, L. R., & O'Brien, K. L. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000348 · Cited by 551
Pai, R., Gertz, R. E., & Beall, B. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.1.124-131.2006 · Cited by 543
Bacterial meningitis in children
Sáez-Llorens, X., & McCracken, G. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13693-8 · Cited by 533
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Griffin, M. R., Zhu, Y., Moore, M. R., Whitney, C. G., & Grijalva, C. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209165 · Cited by 506
Self-citationEffect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Hsu, H. E., Shutt, K. A., Moore, M. R., Beall, B. W., Bennett, N. M., Craig, A. S., Farley, M. M., Jorgensen, J. H., Lexau, C. A., Petit, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800836 · Cited by 497
Self-citationFile, T. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15021-0 · Cited by 491
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
Moore, M. R., Gertz, Jr., Woodbury, R. L., Barkocy‐Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M., Harrison, L. H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528996 · Cited by 480
Self-citationFeikin, D. R., Kagucia, E. W., Loo, J. D., Link-Gelles, R., Puhan, M. A., Cherian, T., Levine, O. S., Whitney, C. G., O’Brien, K. L., Moore, M. R., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001517 · Cited by 470
“There was a lag of at least 2 years before significant decreases in VT IPD rates were observed, an expected finding as the level of herd protection will depend on the accumulated size of the vaccinated group [47].”
BackgroundSelf-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Mechanisms of microbial traversal of the blood–brain barrier
Kim, K. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1952 · Cited by 466
Poehling, K. A., Talbot, T. R., Griffin, M. R., Craig, A. S., Whitney, C. G., Zell, E., Lexau, C. A., Thomas, A. R., Harrison, L. H., Reingold, A. L., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1668 · Cited by 463
Self-citationAcute bacterial meningitis in infants and children
Kim, K. S. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70306-8 · Cited by 454
Janssens, J.-P., & Krause, K.-H. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00931-4 · Cited by 440
Kaplan, S. L., Mason, E. O., Wald, E. R., Schutze, G. E., Bradley, J. S., Tan, T. Q., Hoffman, J. A., Givner, L. B., Yogev, R., & Barson, W. J. (2004) · Pediatrics · doi:10.1542/peds.113.3.443 · Cited by 417
The Pneumococcus: Epidemiology, Microbiology, and Pathogenesis
Henriques-Normark, B., & Tuomanen, E. I. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010215 · Cited by 411
Asthma as a risk factor for invasive pneumococcal disease
Talbot, T. R., Hartert, T. V., Mitchel, E., Halasa, N. B., Arbogast, P. G., Poehling, K. A., Schaffner, W., Craig, A. S., & Griffin, M. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044113 · Cited by 395
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub2 · Cited by 387
Antimicrobial-resistant bacteria in the community setting
Furuya, E. Y., & Lowy, F. D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1325 · Cited by 386
Antimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 381
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
von Gottberg, A., de Gouveia, L., Tempia, S., Quan, V., Meiring, S., von Mollendorf, C., Madhi, S. A., Zell, E. R., Verani, J. R., O’Brien, K. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401914 · Cited by 373
Self-citationPichichero, M. E., & Casey, J. R. (2007) · JAMA · doi:10.1001/jama.298.15.1772 · Cited by 367
Population genomics of post-vaccine changes in pneumococcal epidemiology
Croucher, N. J., Finkelstein, J. A., Pelton, S. I., Mitchell, P. K., Lee, G. M., Parkhill, J., Bentley, S. D., Hanage, W. P., & Lipsitch, M. (2013) · Nature Genetics · doi:10.1038/ng.2625 · Cited by 365
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Dalhoff, A. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/976273 · Cited by 354
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
French, N., Gordon, S. B., Mwalukomo, T., White, S. A., Mwafulirwa, G., Longwe, H., Mwaiponya, M., Zijlstra, E. E., Molyneux, M. E., & Gilks, C. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903029 · Cited by 352
Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens
Lindahl, G., Stålhammar-Carlemalm, M., & Areschoug, T. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.102-127.2005 · Cited by 349
CD4 + T cells mediate antibody-independent acquired immunity to pneumococcal colonization
Malley, R., Trzcinski, K., Srivastava, A., Thompson, C. M., Anderson, P. W., & Lipsitch, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501254102 · Cited by 346
Casey, J. R., Adlowitz, D. G., & Pichichero, M. E. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c1bc48 · Cited by 345
Huang, S. S., Platt, R., Rifas-Shiman, S. L., Pelton, S. I., Goldmann, D., & Finkelstein, J. A. (2005) · Pediatrics · doi:10.1542/peds.2004-2338 · Cited by 344
Munoz-Almagro, C., Jordan, I., Gene, A., Latorre, C., Garcia-Garcia, J. J., & Pallares, R. (2008) · Clinical Infectious Diseases · doi:10.1086/524660 · Cited by 333
Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S., & Lemon, K. P. (2016) · mBio · doi:10.1128/mbio.01725-15 · Cited by 332
Pai, R., Moore, M. R., Pilishvili, T., Gertz, R. E., Whitney, C. G., Beall, B., & Active Bacterial Core Surveillance Team (2005) · The Journal of Infectious Diseases · doi:10.1086/498043 · Cited by 330
Self-citationBrueggemann, A. B., Peto, T. E. A., Crook, D. W., Butler, J. C., Kristinsson, K. G., & Spratt, B. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/423820 · Cited by 329
The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults
Kyaw, M. H., Rose, Jr., Fry, A. M., Singleton, J. A., Moore, Z., Zell, E. R., Whitney, C. G., & Active Bacterial Core Surveillance Program of the Emerging Infections Program Network (2005) · The Journal of Infectious Diseases · doi:10.1086/431521 · Cited by 328
Self-citationBlack, S., Shinefield, H., Baxter, R., Austrian, R., Bracken, L., Hansen, J., Lewis, E., & Fireman, B. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000129685.04847.94 · Cited by 324
Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
Laupland, K. B., & Church, D. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-14 · Cited by 323
Isaacman, D. J., McIntosh, E. D., & Reinert, R. R. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.05.010 · Cited by 321
Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence
Weinberger, D. M., Trzciński, K., Lu, Y.-J., Bogaert, D., Brandes, A., Galagan, J., Anderson, P. W., Malley, R., & Lipsitch, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000476 · Cited by 314
Nigrovic, L. E. (2007) · JAMA · doi:10.1001/jama.297.1.52 · Cited by 306
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296
Antimicrobial resistance in developing countries. Part II: strategies for containment
Okeke, I. N., Klugman, K. P., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Laxminarayan, R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70217-6 · Cited by 290
Microbiota-Targeted Therapies: An Ecological Perspective
Lemon, K. P., Armitage, G. C., Relman, D. A., & Fischbach, M. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004183 · Cited by 286
Regev‐Yochay, G., Raz, M., Dagan, R., Porat, N., Shainberg, B., Pinco, E., Keller, N., & Rubinstein, E. (2004) · Clinical Infectious Diseases · doi:10.1086/381547 · Cited by 282
Antimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 276
Daniels, C. C., Rogers, P. D., & Shelton, C. M. (2016) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-21.1.27 · Cited by 273
Zhou, F., Shefer, A., Kong, Y., & Nuorti, J. P. (2008) · Pediatrics · doi:10.1542/peds.2007-0619 · Cited by 273
Andreola, B., Bressan, S., Callegaro, S., Liverani, A., Plebani, M., & Da Dalt, L. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31806215e3 · Cited by 271
Increasing Hospital Admissions for Pneumonia, England
Trotter, C. L., Stuart, J. M., George, R., & Miller, E. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1405.071011 · Cited by 271
Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Huang, S. S., Hinrichsen, V. L., Stevenson, A. E., Rifas-Shiman, S. L., Kleinman, K., Pelton, S. I., Lipsitch, M., Hanage, W. P., Lee, G. M., & Finkelstein, J. A. (2009) · Pediatrics · doi:10.1542/peds.2008-3099 · Cited by 269
Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
Loeffler, J. M., Djurkovic, S., & Fischetti, V. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.11.6199-6204.2003 · Cited by 269
de Roux, A., Schmöele‐Thoma, B., Siber, G. R., Hackell, J. G., Kuhnke, A., Ahlers, N., Baker, S. A., Razmpour, A., Emini, E. A., Fernsten, P. D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/529142 · Cited by 267
Streptococcus pneumoniae Serotype 19A in Children, South Korea
Choi, E. H., Kim, S. H., Eun, B. W., Kim, S. J., Kim, N. H., Lee, J., & Lee, H. J. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070807 · Cited by 262
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Sun, B., Ji, Z., Liao, Y.-P., Wang, M., Wang, X., Dong, J., Chang, C. H., Li, R., Zhang, H., Nel, A. E., et al. (2013) · ACS Nano · doi:10.1021/nn404211j · Cited by 262
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Levine, M. M. (2010) · BMC Biology · doi:10.1186/1741-7007-8-129 · Cited by 261
O’Brien, K. L., Millar, E. V., Zell, E. R., Bronsdon, M., Weatherholtz, R., Reid, R., Becenti, J., Kvamme, S., Whitney, C. G., & Santosham, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/521833 · Cited by 260
Self-citationSimonsen, L., Taylor, R. J., Young-Xu, Y., Haber, M., May, L., & Klugman, K. P. (2011) · mBio · doi:10.1128/mbio.00309-10 · Cited by 256
Hammitt, L. L., Bruden, D. L., Butler, J. C., Baggett, H. C., Hurlburt, D. A., Reasonover, A., & Hennessy, T. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/503805 · Cited by 254
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Nigrovic, L. E., Malley, R., Macias, C. G., Kanegaye, J. T., Moro-Sutherland, D. M., Schremmer, R. D., Schwab, S. H., Agrawal, D., Mansour, K. M., Bennett, J. E., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-3275 · Cited by 226
Emergency diagnosis and treatment of adult meningitis
Fitch, M. T., & van de Beek, D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70050-6 · Cited by 189
How do viral infections predispose patients to bacterial infections?
Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183
Review: Pathophysiology and treatment of bacterial meningitis
Hoffman, O., & Weber, J. R. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609337975 · Cited by 179
Abdullahi, O., Nyiro, J., Lewa, P., Slack, M., & Scott, J. A. G. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814da70c · Cited by 168
Quandelacy, T. M., Viboud, C., Charu, V., Lipsitch, M., & Goldstein, E. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwt235 · Cited by 144
Bacterial pneumonia and pandemic influenza planning.
Gupta, R. K., George, R., & Nguyen-Van-Tam, J. S. (2008) · Emerging infectious diseases · doi:10.3201/eid1408.070751 · Cited by 132
Acute Bacterial Meningitis in Infants and Children: Epidemiology and Management
Agrawal, S., & Nadel, S. (2011) · Pediatric Drugs · doi:10.2165/11593340-000000000-00000 · Cited by 99
Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?
Anderson, E. J., Campbell, J. D., Creech, C. B., Frenck, R., Kamidani, S., Munoz, F. M., Nachman, S., & Spearman, P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1425 · Cited by 89
Rudolf, I., Bakonyi, T., Šebesta, O., Mendel, J., Peško, J., Betášová, L., Blažejová, H., Venclíková, K., Straková, P., Nowotny, N., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.31.20867 · Cited by 65
Lee, S. H., Chen, S.-Y., Chien, J.-Y., Lee, T.-F., Chen, J.-M., & Hsueh, P.-R. (2019) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2019.04.005 · Cited by 54
Metadata
- Authors
- Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., Facklam, R. R., Jorgensen, J. H., & Schuchat, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05
- Volume
- 348
- Issue
- 18
- Pages
- 1737-1746
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2103637444
- Cited by
- 2,228
- References
- 20
- FWCI
- 105.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.